US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 18.250
- -0.010-0.05%
Close Nov 22 16:00 ET
1.59BMarket Cap-3984P/E (TTM)
18.930High18.030Low1.10MVolume18.400Open18.260Pre Close20.37MTurnover1.49%Turnover RatioLossP/E (Static)87.03MShares20.33052wk High-52.14P/B1.35BFloat Cap5.12052wk Low--Dividend TTM73.88MShs Float37.040Historical High--Div YieldTTM4.93%Amplitude0.000Historical Low18.470Avg Price1Lot Size
Travere Therapeutic Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 69.56%62.9M | 68.08%54.12M | 33.95%41.37M | 32.69%145.24M | 53.58%45.06M | 32.13%37.1M | -40.56%32.2M | -36.30%30.89M | -16.97%109.46M | 176.39%29.34M |
| Operating revenue | 69.56%62.9M | 68.08%54.12M | 33.95%41.37M | 32.69%145.24M | 53.58%45.06M | 32.13%37.1M | -40.56%32.2M | -36.30%30.89M | -16.97%109.46M | 176.39%29.34M |
| Cost of revenue | 26.14%1.63M | 41.94%2.06M | -63.72%1.5M | 159.05%11.45M | 425.81%4.56M | 15.71%1.29M | -29.21%1.45M | 93.87%4.15M | 15.77%4.42M | 181.12%868K |
| Gross profit | 71.12%61.27M | 69.32%52.06M | 49.09%39.87M | 27.37%133.79M | 42.23%40.5M | 32.81%35.81M | -41.01%30.74M | -42.30%26.74M | -17.95%105.04M | 176.26%28.47M |
| Operating expense | -8.64%117.3M | -11.57%119.11M | 44.10%178.85M | 20.17%510.53M | 7.09%123.33M | 17.18%128.39M | 19.56%134.7M | 20.03%124.11M | 29.75%424.85M | 61.14%115.17M |
| Selling and administrative expenses | -3.22%65.62M | -5.02%64.78M | -2.62%64.22M | 34.44%265.54M | 11.39%63.59M | 29.34%67.8M | 28.74%68.2M | 40.95%65.95M | 56.41%197.52M | 208.97%57.09M |
| -General and administrative expense | -3.22%65.62M | -5.02%64.78M | -2.62%64.22M | 34.44%265.54M | 11.39%63.59M | 29.34%67.8M | --68.2M | --65.95M | 56.41%197.52M | --57.09M |
| Research and development costs | -14.71%51.68M | -18.29%54.33M | 97.08%114.63M | 7.77%244.99M | 2.86%59.75M | 6.03%60.59M | 11.41%66.49M | 2.74%58.16M | 13.01%227.33M | 9.60%58.09M |
| Operating profit | 39.49%-56.03M | 35.50%-67.05M | -42.73%-138.98M | -17.80%-376.74M | 4.46%-82.84M | -12.08%-92.59M | -71.69%-103.95M | -70.67%-97.37M | -60.37%-319.81M | 20.32%-86.7M |
| Net non-operating interest income expense | -73.75%793K | -28.58%1.63M | 306.03%3.23M | 320.22%10.43M | 1,585.21%4.33M | 514.97%3.02M | 204.34%2.29M | 135.58%796K | 73.21%-4.74M | 105.88%257K |
| Non-operating interest income | -38.89%3.57M | -13.81%4.42M | 65.44%6.03M | 246.85%21.77M | 129.60%7.15M | 178.06%5.84M | 555.75%5.13M | 1,211.51%3.65M | 214.90%6.28M | 1,219.92%3.12M |
| Non-operating interest expense | -1.56%2.78M | -1.93%2.79M | -1.75%2.8M | 2.91%11.33M | -1.29%2.82M | -0.28%2.82M | -4.34%2.84M | 13.32%2.85M | -44.04%11.01M | -38.00%2.86M |
| Other net income (expense) | 18.51%397K | -1,963.68%-4.15M | -124.14%-21K | -48.39%-9.8M | -1,249.08%-10.02M | 157.17%335K | 95.27%-201K | 100.52%87K | -2,958.87%-6.6M | -96.43%872K |
| Special income (charges) | ---123K | ---653K | ---259K | -50.36%-11.39M | ---11.39M | --0 | --0 | --0 | ---7.58M | --0 |
| -Less：Restructuring and merger&acquisition | --123K | --653K | --259K | --11.39M | --11.39M | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.58M | --0 |
| Other non- operating income (expenses) | 55.22%520K | -1,638.81%-3.5M | 173.56%238K | 63.66%1.59M | 57.57%1.37M | 157.17%335K | -130.36%-201K | 234.62%87K | 321.65%974K | 92.07%872K |
| Income before tax | 38.54%-54.84M | 31.71%-69.57M | -40.71%-135.77M | -13.58%-376.11M | -3.45%-88.53M | -6.33%-89.23M | -52.09%-101.87M | -27.09%-96.49M | -52.69%-331.16M | 3.60%-85.57M |
| Income tax | -800.00%-84K | 30.77%85K | 144.87%191K | -28.75%223K | 7.94%68K | -91.72%12K | 22.64%65K | 50.00%78K | -23.47%313K | 1,475.00%63K |
| Net income | -136.36%-54.81M | 17.78%-70.41M | -57.60%-136.06M | 60.00%-111.4M | -36.99%-90.17M | 316.40%150.74M | -27.74%-85.63M | -13.64%-86.33M | -54.63%-278.48M | -27.63%-65.82M |
| Net income continuous Operations | 38.65%-54.75M | 31.67%-69.65M | -40.80%-135.96M | -13.54%-376.33M | -3.46%-88.6M | -6.16%-89.24M | -52.06%-101.93M | -27.11%-96.56M | -52.54%-331.47M | 3.53%-85.64M |
| Net income discontinuous operations | -100.02%-59K | -104.64%-757K | -101.01%-103K | 400.01%264.93M | -107.96%-1.58M | 1,565.69%239.98M | --16.3M | --10.23M | 42.43%52.99M | --19.81M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -136.36%-54.81M | 17.78%-70.41M | -57.60%-136.06M | 60.00%-111.4M | -36.99%-90.17M | 316.40%150.74M | -27.74%-85.63M | -13.64%-86.33M | -54.63%-278.48M | -27.63%-65.82M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -136.36%-54.81M | 17.78%-70.41M | -57.60%-136.06M | 60.00%-111.4M | -36.99%-90.17M | 316.40%150.74M | -27.74%-85.63M | -13.64%-86.33M | -54.63%-278.48M | -27.63%-65.82M |
| Basic earnings per share | -135.53%-0.7 | 19.47%-0.91 | -38.58%-1.76 | 65.68%-1.5 | -14.56%-1.18 | 280.73%1.97 | -7.62%-1.13 | -5.83%-1.27 | -45.18%-4.37 | -22.62%-1.03 |
| Diluted earnings per share | -135.53%-0.7 | 19.47%-0.91 | -38.58%-1.76 | 65.68%-1.5 | -14.56%-1.18 | 280.73%1.97 | -7.62%-1.13 | -5.83%-1.27 | -45.18%-4.37 | -22.62%-1.03 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data